Radiology Imaging, Diagnostic Imaging, Medical Imaging News, Education, Resources

Health Imaging Hub - YouTube Health Imaging Hub - YouTube Health Imaging Hub - Facebook Health Imaging Hub - Linkedin Health Imaging Hub - RSS Feed
You are in PORTALS Cardiac Imaging GRS Selects MedStar Health Research Institute (MHRI) as Comprehensive Cardiac Imaging Corelab

GRS Selects MedStar Health Research Institute (MHRI) as Comprehensive Cardiac Imaging Corelab

E-mail Print PDF
Share

Cardiac imaging news

Global Research Services, LLC (GRS), an international cardiovascular Clinical Research Organization (CRO), announced its partnership with MedStar Health Research Institute (MHRI)’s Cardiovascular Core Laboratories, a major provider of cardiovascular imaging research services. MHRI is known by its reputation in cardiovascular corelab services, cardiac imaging technology and established experience in research.

According to the agreement, GRS offers clients direct and secure data transfer of cardiac imaging information from MHRI for incorporation into Sponsors’ Phase I-IV investigational drug and device clinical development programs. The agreement ensures GRS’ expansion in clinical trials that require evaluation of cardiovascular endpoints. MHRI will act as the preferred corelab for cardiac evaluations that will include 2D and 3D echocardiography, cardiac MRI, multi-slice CT, carotid intima-media thickness (IMT), intravascular ultrasound (IVUS) and quantitative coronary angiography (QCA).

Bruce Garrett, MD, President and CEO, GRS, stated: “GRS has a 25 year history in cardiovascular clinical trial conduct. We wanted to work with MHRI to offer our clients the top international service provider for professional and accurate cardiac evaluations that seamlessly integrate into our organizational systems.” Internationally recognized expert in cardiac ultrasound Neil Weissman, MD, FACC, FAHA, FASE, President, MHRI, added: “The working agreement with GRS fits our mission of providing top cardiac imaging services to advance healthcare. We both benefit from working together and achieving excellence in trial conduct on behalf of our sponsors.”


Share